Peter Zdziarski/LinkedIn
Apr 13, 2026, 17:41
Peter Zdziarski: Glanzmann’s Research Foundation Listed as GT Patient Organization on NORD
Peter Zdziarski, Founder and Marketing Director of Glanzmann Thrombasthenia Advocacy Network, shared a post on LinkedIn:
“Proud to share that the Glanzmann’s Research Foundation, Inc. is now listed as a patient organization for GT on the National Organization for Rare Disorders website.
This is a meaningful step in helping more individuals and families affected by Glanzmann Thrombasthenia find trusted information and a supportive community of actual patients that much sooner.
Grateful to NORD for the work they do to elevate rare disease organizations and connect people to the resources they need.”
More posts featuring Peter Zdziarski on Hemostasis Today.
-
Oct 20, 2026, 22:59Building Effective Patient Advocacy Through Collaboration Between Patients and Clinicians – EHC
-
Oct 20, 2026, 21:22Intezar Mehdi: When Prolonged Bleeding May Indicate an Underlying Bleeding Disorder
-
Oct 20, 2026, 21:06Nandini Pethe: Sharing My Experience as a Caregiver in the HOPE Factor Resource Guide
-
Oct 20, 2026, 16:51Suzan Nakasendwa: A Growing Stroke Challenge in Uganda
-
Oct 20, 2026, 16:38Steve Moon: How Does Smoking Cessation Duration Affect Ischemic Stroke Risk
-
Oct 20, 2026, 16:25Cedrice Mentor: Reducing Platelet Wastage Through Cold Storage
-
Oct 20, 2026, 16:09Thirunavukkarasu Angappan: Can a Purified Fibrinogen Concentrate Replace Cryoprecipitate
-
Oct 20, 2026, 16:01Kalyan Roy: Platelet Conservation Through Evidence-Based Transfusion Practice
-
Oct 20, 2026, 15:28Stacy E. Croteau: 33 Countries, One Mission – Better Bleeding Disorder Care